Warning Signs That Mean Get Emergency Eye Care Today
Some sudden vision problems in older adults are an emergency. One cause is giant cell arteritis. It is a disease that inflames and swells arteries. The swelling can cut off blood to the nerve of the eye. Doctors treat it right away with high-dose steroids, even before test results come back, to protect the sight you still have1. Call your eye doctor or go to an emergency room today if you are over 50 and have any of these signs:
- Sudden loss or dimming of vision in one eye, even if only part of your view
- Vision that blacks out for a few seconds and then comes back
- A new headache, or a headache that feels different, often near the temple
- Aching or tiredness in the jaw when you chew
- A tender, sore scalp, for example when you comb your hair
- Double vision
Here is the calmer side of that list. This disease can be treated, and care works best when it starts early. Giant cell arteritis is an eye emergency mainly because the other eye can also be harmed within days if it is not treated2. Getting seen today is the most helpful thing you can do.
This disease is rare in younger people. Giant cell arteritis affects people over the age of 50, and it grows more common with each decade after that1. If you are under 50, sudden vision changes still need prompt care, but this cause is very unlikely. If you are over 50, a new headache plus jaw pain when chewing and any vision change is the pattern to act on. Go in the same day. Do not wait for a routine visit.
Giant Cell Arteritis and 'Eye Stroke' at a Glance
An 'eye stroke' is a plain term for a sudden loss of blood flow inside the eye or to its nerve. Most eye strokes come from a blocked blood vessel. This page is about a different cause. In giant cell arteritis, the most common way sight is lost is arteritic anterior ischemic optic neuropathy, which means the front of the optic nerve loses its blood supply because the small arteries feeding it are inflamed and closed off2. The key point is simple. This cause is driven by inflammation you can treat with medicine, so acting fast matters.
If you are over 50 and have sudden vision loss with head or jaw symptoms, treat it as urgent. Get seen the same day. If your symptoms are mild or have been there a long time, you still deserve an eye exam, but you are likely not in the emergency picture this page describes. The rest of this page explains what the disease is, how it is found, how it is treated, and what a realistic outlook looks like.
What Giant Cell Arteritis Is and How It Threatens Sight
Giant cell arteritis, also called temporal arteritis, is a disease that inflames and thickens the walls of some arteries. The inflammation can narrow or close the small posterior ciliary arteries that feed the optic nerve, and this loss of blood flow is the reason sight can be lost in this disease2. Because the problem is inflammation and not a simple clot, steroids that calm the inflammation are the treatment. That is different from how a typical stroke is handled.
Giant cell arteritis occurs in about 17 of every 100,000 people over age 50 each year, and it affects women more often than men1. It is more common in people of Northern European background. It is uncommon overall. But among older adults with a new headache and a vision change, it is one of the conditions doctors most want to catch early. The reason is plain: missing it can cost sight for good.
Doctors call this a can't-miss diagnosis because it is a whole-body disease that first shows up in the eye. In one large group of biopsy-confirmed patients, about 14 of every 100 lost vision permanently, and most of that loss happened before steroids were started1. Sight lost this way rarely comes back. So the whole goal of care is to prevent that loss by treating early, and to protect a second eye that still sees well.
What Causes It and What Raises Your Risk
The exact trigger is not fully known. It is an autoimmune process, which means the body's own immune system attacks the lining of the arteries. This draws in inflammatory cells, including the large 'giant cells' that give the disease its name. It often overlaps with polymyalgia rheumatica, a related condition that causes shoulder and hip stiffness, which is present in about 40 to 60 of every 100 people with giant cell arteritis1. You did not cause this, and nothing you did brought it on.
The main risk factors are outside your control. Being over 50 is the most important risk factor, and the disease is very rare before that age1. Being a woman and having Northern European ancestry also raise the risk. Having polymyalgia rheumatica is another marker, since the two conditions often travel together.
This disease is not caused by eye strain, reading, screen time, diet, or stress. It is not contagious. It is not the result of anything you ate or failed to do. Getting this right matters, because blaming yourself can delay the one action that helps. That action is getting seen quickly when the warning signs appear.
Signs, Symptoms, and Look-Alikes
Beyond the eye, this disease usually shows up with head and body symptoms. A new headache is present in about two-thirds of patients, and jaw pain or tiredness when chewing, scalp tenderness, fever, and unexplained weight loss are also common1. These general symptoms are easy to blame on aging or a minor illness. That is exactly why pairing any of them with a vision change should raise the alarm.
The eye warning that most often comes first is a brief blackout of vision. A temporary loss of vision that comes and goes can appear before permanent loss, which makes it an important early warning rather than something to wait out2. Sudden vision loss in one eye and double vision are the other key eye symptoms. If you notice a fleeting blackout, do not wait to see if it happens again. That flicker can be the last warning before lasting loss, and prompt care is what prevents it.
Because the symptoms are general, this disease can be mistaken for a migraine, a tension headache, a dental problem, or a typical eye stroke from a clot. The feature that sets it apart is the pattern. It is an older adult with a new headache, jaw symptoms when chewing, a sore scalp, and a vision change. When that pattern is present, doctors test for inflammation quickly rather than assuming a milder cause.
How Doctors Diagnose It
The first step is usually simple blood work that measures inflammation. Two markers, the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), are usually high in giant cell arteritis, with the sedimentation rate often above 50 and sometimes above 1001. These tests are fast and can be done the same day. They do not confirm the disease on their own, but they help doctors decide how urgently to act.
The test that confirms the disease is a temporal artery biopsy. A small piece of an artery near the temple is removed and looked at under a microscope. Biopsy is the standard confirming test, but it can be normal in some true cases, so a normal biopsy does not fully rule the disease out1. Treatment is not delayed while waiting for the biopsy result, because the risk of losing sight during a delay is too high.
Sometimes the disease attacks sight with no other symptoms at all. About 21 of every 100 patients with vision loss from this disease have no body symptoms like headache or jaw pain, and vision loss is their only complaint2. This is one more reason an older adult with sudden vision loss should be checked for giant cell arteritis, even without a headache. Your care team weighs your symptoms and test results together.
How It Is Treated
The main treatment is high-dose corticosteroids, which are strong anti-inflammatory medicines such as prednisone. The usual approach is oral prednisone around 40 to 60 milligrams a day, with intravenous methylprednisolone about 1 gram a day for about three days when sight is already threatened1. Your doctor sets the exact dose. This page describes the usual plan and does not replace the plan your doctor makes for you.
It can feel backward to start a strong medicine before a test confirms the diagnosis. But the timing is on purpose. Treatment is started right away when the disease is suspected and is never held back while waiting for biopsy results, because a delay can cost vision that will not return1. The main goal of treatment is to limit further vision loss rather than to restore lost sight, since only a small share of already-affected eyes regain vision2. That is why protecting the second eye is so central.
Steroids are needed for a long time, so doctors often add a second medicine to lower the total steroid dose. In the GiACTA trial, adding tocilizumab (a biologic medicine) kept about 56 of every 100 patients in steroid-free remission at one year, compared with about 14 of every 100 on steroids alone1. The steroid dose is lowered slowly over many months, and because relapses are common as the dose comes down, treatment often continues for a year or more1. Your rheumatologist guides this longer plan.
Risks, Complications, and a Realistic Outlook
The most feared complication is losing sight. In a large biopsy-confirmed group, about 14 of every 100 people lost vision permanently, and once it is lost from optic nerve damage it usually does not recover1. That number is exactly why early treatment matters. The goal is to stop further loss and protect the fellow eye, and started in time, treatment usually does that. The scary number and the hopeful action belong together.
Steroids are life-changing for this disease, but they carry their own risks over months of use. These can include bone thinning, higher blood sugar, weight gain, mood changes, and a higher chance of infection. This is why doctors add steroid-sparing medicines and lower the dose as safely and quickly as the disease allows. Your care team will usually add bone protection and watch your blood sugar while you are on treatment.
For most people who are treated promptly, the disease is controlled and further vision loss is prevented, though treatment and check-ups continue for a year or more. This outlook is a population average, not a promise about any one person. Some people relapse and need dose changes. A few have already lost vision before treatment begins. The steady theme is that speed of treatment is the part most within reach.
When to Call or See a Doctor
Seek care the same day if you are over 50 and have sudden or partial vision loss in one eye, a vision blackout that comes and goes, a new or changed headache, jaw pain when chewing, a sore scalp, or double vision. If vision loss is sudden and complete, treat it as an emergency and go to an emergency room. Acting on the first eye symptom, not the second, is what most often saves sight.
If you are already being treated, keep every follow-up visit. Your medicine dose is adjusted based on your symptoms and blood tests, and relapses are most common as the steroid dose is lowered. Report any return of headache, jaw symptoms, or vision change between visits rather than waiting for the next appointment. This is how your team keeps the disease from flaring.
This disease is managed by more than one kind of doctor. An eye specialist (an ophthalmologist, often a neuro-ophthalmology or retina specialist) checks the threat to your sight. A rheumatologist usually manages the long-term steroid and steroid-sparing treatment. If you first reach a primary care doctor or an emergency room, say plainly that you are worried about giant cell arteritis. Naming it helps the team move quickly.
Common Questions About Giant Cell Arteritis and Eye Stroke
No. A regular stroke usually comes from a blocked or burst blood vessel, most often a clot. Giant cell arteritis causes an 'eye stroke' through inflammation that swells and closes the arteries feeding the optic nerve. The difference matters because the treatment is different. This disease responds to steroids that calm the inflammation, and starting them quickly is what protects your sight and your other eye.
Because waiting can cost vision that will not return. When this disease is strongly suspected, treatment starts right away and is not held back for biopsy results. The biopsy is still done, usually within about two weeks, and steroids do not erase its findings in that short window. The order is on purpose: protect the eye first, confirm the diagnosis second.
Usually not. Vision lost from optic nerve damage in this disease rarely recovers, and only a small share of affected eyes regain sight even with steroids. The main benefit of prompt treatment is preventing further loss, especially protecting a second eye that still sees. This is why the brief, temporary vision blackouts that can come first are such important warnings to act on.
Diagnosis usually starts with blood tests for inflammation (ESR and CRP), which are often high and can be done the same day. A temporal artery biopsy confirms it, though a normal biopsy does not fully rule it out, because the test misses some true cases. Your doctor combines the test results with your symptoms and how quickly answers are needed to decide the next step.
In a large biopsy-confirmed group, about 14 of every 100 people had permanent vision loss, and much of that loss happened before treatment began. Starting steroids promptly is aimed at preventing further loss and protecting the fellow eye. The single biggest factor you can influence is how quickly you get care once warning signs appear, which is why acting the same day matters so much.
Treatment is not brief. The steroid dose is lowered slowly over many months, and treatment often continues for a year or more, sometimes with a low maintenance dose for longer. Many people also take a steroid-sparing medicine such as tocilizumab to reduce the total steroid dose. Relapses are common as the dose comes down, so your doctor adjusts the plan based on symptoms and blood tests. Stopping treatment on your own can let the disease flare and threaten sight again.
More Questions, and What to Ask Your Doctor
Yes, and it is one of the more telling ones. Jaw pain, aching, or tiredness that comes on while chewing and eases with rest reflects reduced blood flow to the chewing muscles from the same artery inflammation. In an adult over 50, this jaw symptom together with a new headache or any vision change is a pattern that warrants same-day care rather than a wait-and-see approach.
Yes, and preventing that is much of the point of urgent treatment. If the disease is not treated, the second eye can be affected within about one to two weeks of the first. That short window is why doctors treat right away when the condition is suspected. For someone who has already lost vision in one eye, protecting the other eye becomes the central, time-sensitive goal of care.
Not a replacement, but a partner. Tocilizumab is added to steroids to help control the disease while using less steroid over time, which lowers steroid side effects. In the GiACTA trial, adding it kept far more patients in steroid-free remission at one year than steroids alone. Steroids are still the urgent first treatment when sight is threatened. Tocilizumab is part of the longer-term plan your rheumatologist manages.
A temporary blackout of vision that returns on its own can be the last warning before permanent loss in this disease, so ignoring it is risky. It is not a reason to panic, but it is a reason to be seen the same day if you are over 50, especially with any headache or jaw symptoms. Getting checked promptly is what allows treatment to start before lasting damage occurs.
- Do my symptoms and blood tests suggest giant cell arteritis, and how urgently should I be treated?
- Should I start steroids now, and will I have a temporal artery biopsy to confirm the diagnosis?
- What steroid dose am I starting on, and should I also take a steroid-sparing medicine such as tocilizumab?
- What side effects of long-term steroids should I watch for, and how will you protect my bones and blood sugar?
- What symptoms mean the disease is flaring or my other eye is at risk, and who do I call the same day?